SEC Form 4 · accession 0001225208-18-016813
Edwards Lifesciences Corp · EW
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Catherine M. Szyman
Officer — CVP, Critical Care & Vascular
Period of report
Dec 14, 2018
Accepted (ET)
Dec 18, 2018 · 4:37 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001099800
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Dec 14, 2018 | S | 372 | $162.66 | D | 27,028 | D | |
| Common Stock | Dec 14, 2018 | S | 328 | $162.66 | D | 2,958 | I | By Spouse |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 29, 2018.
- F2This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person's husband on August 29, 2018.
Remarks
This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the Reporting Person.